trial

1 min read

Human Trial Finds Supplement Improves Age-Related Defects to Improve Cognition, Muscle Strength

The results of a pilot human clinical trial conducted by researchers at Baylor College of Medicine suggest that taking a supplement known as GlyNAC—a combination of glycine and N-acetylcysteine (NAC) as precursors of the natural antioxidant glutathione (GSH)—could improve many age-associated deficiencies in older people, to improve muscle strength and cognition, and promote healthy aging.

The small-scale study showed that older humans taking GlyNAC for 24 weeks demonstrated improvements in many characteristic defects of aging, including glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, body fat, muscle strength, genomic toxicity, gait speed, exercise capacity, and cognitive function.

1 min read

Overnight Health Care: CDC director warns of ‘avoidable surge’ of COVID-19 amid relaxing precautions | AstraZeneca says COVID-19 vaccine found 79 percent effective in US trial | Trump says Fauci ‘a promoter more than anything’

4 weeks ago Andreas Milano

Welcome to Monday’s Overnight Health Care. If you need more incentive to get vaccinated, Krispy Kreme has you covered.

If you have any tips, email us at [email protected]and [email protected], and follow us on Twitter at @NateWeixel and @PeterSullivan4

Today: The CDC director is warning that another COVID surge is avoidable, AstraZeneca published initial U.S. results for its vaccine, and more states are opening vaccine eligibility.

We’ll start with a warning:

Don’t get careless: CDC director warns of ‘avoidable surge’ of COVID-19 amid relaxing precautions

Centers for Disease Control and Prevention (CDC) Director Rochelle WalenskyRochelle WalenskyThe Hill’s Morning Report

1 min read

AstraZeneca Vaccine Trial Results Are Questioned by U.S. Health Officials

4 weeks ago Andreas Milano

Credit…Alessandro Grassani for The New York Times

Federal health officials said early Tuesday that results from a U.S. trial of AstraZeneca’s Covid-19 vaccine may have relied on “outdated information” that “may have provided an incomplete view of the efficacy data,” casting doubt on an announcement on Monday that had been seen as good news for the British-Swedish company as well as the global vaccination drive.

In a highly unusual statement released after midnight, the National Institute of Allergy and Infectious Diseases said that the

1 min read

Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial | Infectious Diseases of Poverty

1 month ago Andreas Milano

Coronavirus disease-2019 (COVID-19) was discovered in December 2019, it has resulted in a sudden and significant number of hospitalizations and pneumonia-related deaths globally to date [1,2,3]. COVID-19 is associated with morbidity and mortality globally and has been defined as an “international emergency” and characterized as a pandemic by the World Health Organization (WHO) [1]. Currently, this infection is prevalent in more than 215 countries. As of February 21, 2021, over 111.07 million confirmed cases and 2.46 million deaths resulting from COVID-19 have been reported globally [4]. The rapid spread of COVID-19 poses significant economic, social, and healthcare challenges worldwide.

The

1 min read

Dentist-Lawyer Orly Taitz Sues VP Kamala Harris, Claims Trump Impeachment Trial Is Unconstitutional

2 months ago Andreas Milano

Orly Taitz, the conspiracy theorist, dentist, and attorney who led the “birther” movement’s litigation to contest the reality that Barack Obama was born in the United States, is suing Vice President Kamala Harris and Senate Majority Leader Chuck Schumer (D-N.Y.) in an attempt to stop the U.S. Senate from presiding over a trial connected to former President Donald Trump’s historic second impeachment.

In a Thursday press release, Taitz said the lawsuit, filed on behalf of the Defend Our Freedoms Foundation, or DOFF, would attempt to persuade a court that any upcoming

1 min read

Oxford trial to test efficacy of mix of Covid vaccines for individuals

2 months ago Andreas Milano

Volunteers are being sought for a world-first trial to establish the efficacy of giving people a first dose of one vaccine and a second dose of a different vaccine.

The trial, which is being run by Oxford University and is funded by the government’s vaccine taskforce, has been described by ministers as “hugely important”.

It will recruit 820 people over the age of 50 who have not yet had a vaccine, to receive a first dose of either the Oxford/AstraZeneca vaccine or the Pfizer/BioNTech vaccine. Some people will then get an

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30

trial

Human Trial Finds Supplement Improves Age-Related Defects to Improve Cognition, Muscle Strength

Overnight Health Care: CDC director warns of ‘avoidable surge’ of COVID-19 amid relaxing precautions | AstraZeneca says COVID-19 vaccine found 79 percent effective in US trial | Trump says Fauci ‘a promoter more than anything’

AstraZeneca Vaccine Trial Results Are Questioned by U.S. Health Officials

Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial | Infectious Diseases of Poverty

Dentist-Lawyer Orly Taitz Sues VP Kamala Harris, Claims Trump Impeachment Trial Is Unconstitutional

Oxford trial to test efficacy of mix of Covid vaccines for individuals

You may have missed

Canada’s health care workers brace for the painful blow of a punishing third wave

Blood Pressure Support Formula How Does It Work? Price and Benefits Review by HealthyRex

The Real Vaccine Crisis Isn’t About J&J or AstraZeneca, But Unequal Distribution

El Paso County restaurants call the shots in latest change to COVID-19 health orders